Since RhoA knockdown had no observable effect on tumor angiogenesis, it is possible that the increased CXCL12 expression might drive the paracrine stimulation of the RhoA knockdown cancer cells’ invasiveness. The gene discussed is RHOA; the disease is neoplasm.